Inhibitory Effect of Clopidogrel, a P2Y<sub>12</sub> Receptor Antagonist, on Hematogenic Metastasis in B16-BL6 Mouse Melanoma Cells. [PDF]
Yoshikawa N, Xia M, Nakamura K.
europepmc +1 more source
Effect of Microglial Purinergic P2Y12 Receptor on Efficiency of Beta-Amyloid Immunotherapy and Aging
Microglia, as the primary immune cells of the central nervous system (CNS), play a pivotal role in the efficiency of Aβ immunotherapy by facilitating β-amyloid clearance and forming a protective barrier around β-amyloid plaques.
Gabr, Amr Ahmed Mohamed
core
[Treatment] Platelet inhibitors of the P2Y12 receptor
openaire +2 more sources
Inhibiting the P2Y<sub>12</sub> Receptor in Megakaryocytes and Platelets Suppresses Interferon-Associated Responses. [PDF]
Sowa MA +14 more
europepmc +1 more source
Synthesis, preclinical evaluation and pilot clinical study of a P2Y<sub>12</sub> receptor targeting radiotracer [<sup>18</sup>F]QTFT for imaging brain disorders by visualizing anti-inflammatory microglia. [PDF]
Yao B +14 more
europepmc +1 more source
Selective Inhibition of P2Y1 and P2Y12 Receptor Signal Pathways in Platelet Aggregation in Transgenic Cell Lines and Rats by Potassium 2-(1-Hydroxypentyl)-Benzoate, Puerarin and Salvianolic Acid B. [PDF]
Li Y +6 more
europepmc +1 more source
Ticagrelor inverse agonist activity at the P2Y12 receptor is non-reversible versus its endogenous agonist adenosine 5´-diphosphate. [PDF]
Khalil J +10 more
europepmc +1 more source
The thienopyridine P2Y12 receptor antagonists clopidogrel and prasugrel prevent arterial thrombosis and are routinely used following percutaneous coronary intervention. However, the optimal level of P2Y12 blockade to effectively inhibit platelet function
Robert J Buckland +2 more
exaly +4 more sources

